Top

BMC Ophthalmology

Published in:

Open Access 01-12-2017 | Case report

Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery

Authors: Konstantinos Andreanos, Petros Petrou, George Kymionis, Dimitrios Papaconstantinou, Ilias Georgalas

Published in: BMC Ophthalmology | Issue 1/2017

Abstract

Background

We report a case of hemorrhagic occlusive retinal vasculitis (HORV) after prophylactic intracameral vancomycin use during an uneventful cataract surgery treated with early anti-VEGF treatment.

Case presentation

A 51-year-old female underwent uneventful cataract surgery with prophylactic intracameral vancomycin during the procedure. On the seventh post-operative-day, she presented with sudden painful, visual loss. Fundus examination revealed peripheral hemorrhagic retinal vasculitis. She received anti-VEGF therapy to prevent further vision loss and retinal neovascularization due to extensive retinal ischemia. At the 6-month follow-up visit, visual acuity was 20/20 with no sign of neovascularization.

Conclusions

Postoperative HORV is a devastating condition that can occur after otherwise uncomplicated cataract surgery. The nature of this rare condition remains unknown. Early anti-VEGF administration seems to demonstrate favorable results.

Taban M, Beherens A, Newcomb RL, et al. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol. 2005;123:613–20.CrossRefPubMed

Hatch WV, Cernat G, Wong D, Devenyi R, Bell CM. Risk factors for acute endophthalmitis after cataract surgery: a population-based study. Ophthalmology. 2009;116:425–30.CrossRefPubMed

Miller JJ, Scott IU, Flynn HW Jr, Smiddy WE, Newton J, Miller D. Acute onset endophthalmitis after cataract surgery (2000–2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005;139:983–7.CrossRefPubMed

Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group. J Cataract Refract Surg. 2006;32:407–10.CrossRefPubMed

Behndig A, Cochener B, Güell JL, Kodjikian L, Mencucci R, Nuijts RM, Pleyer U, Rosen P, Szaflik JP, Tassignon MJ. Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg. 2013;39(9):1421–31.CrossRefPubMed

Braga-Mele R, Chang DF, Henderson BA, et al. Intracameral antibiotics: safety, efficacy, and preparation. J Cataract Refract Surg. 2014;40:2134–42.CrossRefPubMed

Yoeruek E, Spitzer MS, Saygili O, et al. Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use. J Cataract Refract Surg. 2008;34:2139–45.CrossRefPubMed

Ball JL, Barrett GD. Prospective randomized controlled trial of the effect of intracameral vancomycin and gentamicin on macular retinal thickness and visual function following cataract surgery. J Cataract Refract Surg. 2006;32(5):789–94.CrossRefPubMed

Nicholson LB, Kim BT, Jardón J, et al. Severe bilateral ischemic retinal vasculitis following cataract surgery. Ophthalmic Surg Lasers Imaging Retina. 2014;45:338–42.CrossRefPubMed

10.

Witkin AJ, Chang DF, Jumper JM, Charles S, Eliott D, Hoffman RS, Mamalis N, Miller KM, Wykoff CC. Vancomycin-associated hemorrhagic occlusive retinal vasculitis: clinical characteristics of 36 eyes. Ophthalmology. 2017;124(5):583–95.CrossRefPubMed

11.

Balducci N, Savini G, Barboni P, Ducoli P, Ciardella A. Hemorrhagic occlusive retinal Vasculitis after first eye cataract surgery without subsequent second eye involvement. Ophthalmic Surg Lasers Imaging Retina. 2016;47(8):764–6.CrossRefPubMed

12.

Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol. 2010;55(1):2–34.CrossRefPubMed

13.

Lenci LT, Chin EK, Carter C, Russell SR, Almeida DR. Ischemic retinal vasculitis associated with cataract surgery and Intracameral vancomycin. Case Rep Ophthalmol Med. 2015;2015:683194.PubMedPubMedCentral

Title: Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery
Authors: Konstantinos Andreanos
Petros Petrou
George Kymionis
Dimitrios Papaconstantinou
Ilias Georgalas
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: BMC Ophthalmology / Issue 1/2017
Electronic ISSN: 1471-2415
DOI: https://doi.org/10.1186/s12886-017-0632-y

At a glance: The STEP trials

Springer Medicine

Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery

Abstract

Background

Case presentation

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2017

The increasing prevalence of myopia in junior high school students in the Haidian District of Beijing, China: a 10-year population-based survey

Iris reconstruction using autologous iris preserved in cold balanced salt solution for 8 hours in iatrogenic total iridodialysis during cataract surgery: a case report

Amblyopia treatment of adults with dichoptic training using the virtual reality oculus rift head mounted display: preliminary results

Bilateral Morganella Morganii keratitis in a patient with facial topical corticosteroid-induced rosacea-like dermatitis: a case report

Comparison of efficacy between coaxial microincision and standard-incision phacoemulsification in patients with age-related cataracts: a meta-analysis

27-gauge and 25-gauge vitrectomy day surgery for idiopathic epiretinal membrane